Publications

How much does malaria vector control quality matter: the epidemiological impact of holed nets and inadequate indoor residual spraying.

REHMAN, AM; Coleman, M; Schwabe, C; Baltazar, G; Matias, A; Gomes, IR; Yellott, L; Aragon, C; Nchama, GN; Mzilahowa, T; ROWLAND, M; KLEINSCHMIDT, I;

2011

PloS one, (2011).6 4 10.1371/journal.pone.0019205.

Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.

CHICO, RM; CHANDRAMOHAN, D;

2011

Expert opinion on drug metabolism & toxicology, (2011).7 9 10.1517/17425255.2011.598506.

A research agenda to underpin malaria eradication.

Alonso, PL; Brown, G; Arevalo-Herrera, M; Binka, F; Chitnis, C; Collins, F; Doumbo, OK; GREENWOOD, B; Hall, BF; Levine, MM; Mendis, K; Newman, RD; Plowe, CV; Rodríguez, MH; Sinden, R; Slutsker, L; Tanner, M;

2011

PLoS medicine, (2011).8 1 10.1371/journal.pmed.1000406.

Maternal environment shapes the life history and susceptibility to malaria of Anopheles gambiae mosquitoes.

LORENZ, LM; Koella, JC;

2011

Malaria journal, (2011).10 1 10.1186/1475-2875-10-382.

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

RTS,S Clinical Trials Partnership,; Agnandji, ST; Lell, B; Soulanoudjingar, SS; Fernandes, JF; Abossolo, BP; Conzelmann, C; Methogo, BG N O; Doucka, Y; Flamen, A; Mordmüller, B; Issifou, S; Kremsner, PG; Sacarlal, J; Aide, P; Lanaspa, M; Aponte, JJ; Nhamuave, A; Quelhas, D; Bassat, Q; Mandjate, S; Macete, E; Alonso, P; Abdulla, S; Salim, N; ... Vansadia, P.

2011

The New England journal of medicine, (2011).365 20 10.1056/NEJMoa1102287.

Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.

Estévez, PT; Satoguina, J; NWAKANMA, DC; West, S; CONWAY, DJ; DRAKELEY, CJ;

2011

Malaria journal, (2011).10 1 10.1186/1475-2875-10-104.

Price subsidies and the market for mosquito nets in developing countries: A study of Tanzania's discount voucher scheme.

Gingrich, CD; HANSON, K; MARCHANT, T; Mulligan, J-A; Mponda, H;

2011

Social science & medicine (1982), (2011).73 1 10.1016/j.socscimed.2011.04.028.

A research agenda for malaria eradication: drugs.

MalERA Consultative Group on Drugs,;

2011

PLoS medicine, (2011).8 1 10.1371/journal.pmed.1000402.

Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.

Newton, PN; Green, MD; Mildenhall, DC; Plançon, A; Nettey, H; Nyadong, L; Hostetler, DM; Swamidoss, I; Harris, GA; Powell, K; Timmermans, AE; Amin, AA; Opuni, SK; Barbereau, S; Faurant, C; Soong, RC W; Faure, K; Thevanayagam, J; Fernandes, P; KAUR, H; Angus, B; Stepniewska, K; Guerin, PJ; Fernández, FM;

2011

Malaria journal, (2011).10 1 10.1186/1475-2875-10-352.

Repellent comprising geranylacetone.

Pickett, JA; LOGAN, JG; Birkett, MA; Mordue, AJ;

2011

(2011).